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Abstract
Background. Epidemiological evidence on the association between ambient air pollution and brain tumor 
risk is sparse and inconsistent.
Methods. In 12 cohorts from 6 European countries, individual estimates of annual mean air pollution levels 
at the baseline residence were estimated by standardized land-use regression models developed within the 
ESCAPE and TRANSPHORM projects: particulate matter (PM) ≤2.5, ≤10, and 2.5–10 μm in diameter (PM2.5, 
PM10, and PMcoarse), PM2.5 absorbance, nitrogen oxides (NO2 and NOx) and elemental composition of PM. 
We estimated cohort-specific associations of air pollutant concentrations and traffic intensity with total, 
malignant, and nonmalignant brain tumor, in separate Cox regression models, adjusting for risk factors, and 
pooled cohort-specific estimates using random-effects meta-analyses.
Results. Of 282 194 subjects from 12 cohorts, 466 developed malignant brain tumors during 12 years of 
follow-up. Six of the cohorts also had data on nonmalignant brain tumor, where among 106 786 subjects, 
366 developed brain tumor: 176 nonmalignant and 190 malignant. We found a positive, statistically nonsig-
nificant association between malignant brain tumor and PM2.5 absorbance (hazard ratio and 95% CI: 1.67; 
0.89–3.14 per 10–5/m3), and weak positive or null associations with the other pollutants. Hazard ratio for 
PM2.5 absorbance (1.01; 0.38–2.71 per 10
–5/m3) and all other pollutants were lower for nonmalignant than for 
malignant brain tumors.
Conclusion. We found suggestive evidence of an association between long-term exposure to PM2.5 absorb-
ance indicating traffic-related air pollution and malignant brain tumors, and no association with overall or 
nonmalignant brain tumors.
Key words  
air pollution | brain cancer | brain tumor | traffic
Importance of the study
Increasing brain tumor incidence generated interest in 
environmental exposures. Traffic-related air pollution 
was declared carcinogenic to humans and linked to 
lung cancer. Experimental studies illustrated that parti-
cles can reach the brain causing inflammation and oxi-
dative stress, but the current epidemiological evidence 
on air pollution and brain tumor risk is sparse and 
inconclusive. Within the framework of the European 
Study of Cohorts for Air Pollution Effects (ESCAPE), we 
examined the association between air pollution and 
brain tumor risk in 282 194 subjects from 12 cohorts 
in 6 countries, who developed 466 malignant brain 
tumors during 12 years. Air pollution levels at the resi-
dence were estimated by standardized land-use regres-
sion models for PM  ≤2.5,  ≤10, 2.5–10 μm in diameter 
(PM2.5, PM10, PMcoarse), PM2.5 absorbance, and nitrogen 
oxides (NO2, NOx). We found suggestive evidence of 
an association between the traffic-related metric PM2.5 
absorbance and malignant brain tumors, and no asso-
ciation with overall or nonmalignant brain tumors. The 
strength of the study was availability of data on nonma-
lignant brain tumors.
The average incidence of primary adult brain tumors (non-
malignant or malignant) in Europe in 2012 was 6.6 (7.8 in men 
and 5.6 in women) per 100 000 people and approximately 
half of these were malignant (brain cancers).1 Incidence 
of brain tumors has been increasing in the industrialized 
countries, which is, in part, explained by improvements in 
diagnoses and high-resolution neuroimaging and an aging 
population, but occupational and environmental exposures 
have been suspected to play a role.2 Established brain tumor 
risk factors include age, ionizing radiation to the head, and 
inherited genetic risk,3 while infectious agents, high income, 
white race, exogenous hormone exposure (for nonmalig-
nant tumors in women), occupations in agriculture4 and 
the petrochemical industry, and exposure to landfill pollu-
tion have been identified as potential risk factors.3 Outdoor 
and traffic-related sources of air pollution, such as gasoline 
and diesel engine exhaust, have been classified as carcino-
genic to humans by the International Agency for Research 
on Cancer5,6 and are established risk factors for lung can-
cer and cardiovascular and respiratory diseases.7–9 Still, epi-
demiological evidence relating traffic-related air pollution to 
brain diseases is just emerging. Air pollution was recently 
linked to stroke,10 and the biological mechanism relevant for 
stroke was also suspected of being relevant for neurodegen-
erative diseases, such as Alzheimer’s, Parkinson’s diseases, 
and dementia.11 Experimental evidence in animals showed 
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how particles,11 and most recently mineral magnetite,12 can 
reach the brain, via inhalation or directly through the nose 
and olfactory nerve, and cause neuroinflammation, oxida-
tive stress, and neurodegeneration.11,13–17 Inflammation 
is suggested to be important in the pathogenesis of brain 
cancer.18 Furthermore, gene expression patterns similar to 
that seen in human brain tumors were found in rats after 
exposure to concentrated particles, in particular the coarse 
fraction.19 However, epidemiological evidence is sparse, 
consisting of 2 ecological studies,20,21 3 cohort studies,22–24 
and a case-control study.25 A  US study found association 
between airborne toxicant volatile organic compound emis-
sions at a county level and the incidence of brain cancer,20 
while a recent nationwide study found no association of 
brain cancer incidence and mortality at country level with 
any of 30 different hazardous air pollutants examined.21 The 
earliest cohort study, from 2009, based on the US Cancer 
Prevention Study cohort, found no associations between 
brain cancer mortality (n = 1284) and residential exposure 
to particulate matter (PM) with diameter  <2.5 and 10  µg/
m3 (PM2.5 and PM10) or nitrogen dioxide (NO2).
22 A  study 
from 2011 detected a strong association between long-term 
exposure to nitrogen oxides (NOx) and brain cancer inci-
dence (n = 95) (hazard ratio and 95% CI: 2.28; 1.24–4.17 per 
100 µg/m3) in the Danish Diet, Cancer and Health cohort,23 
which was, however, not reproduced in a nationwide Danish 
case-control study with 4183 brain tumor cases.25 Finally, 
the recent study in the Danish Nurse Cohort (n = 121) found 
no association between brain tumor incidence (malignant or 
nonmalignant) and PM2.5, PM10, or NO2.
24 With air pollution 
established as carcinogenic to humans, suggestive experi-
mental evidence on the biological plausibility, and sparse 
and inconclusive epidemiological evidence, the rationale 
of this study was to examine association between air pollu-
tion and brain tumor in a large study combining information 
from several European cohorts.
In this study, by using the 12 European cohorts within 
the framework of the European Study of Cohorts for Air 
Pollution Effects (ESCAPE; http://www.escapeproject.
eu/),26,27 we aim to examine the association between long-
term exposure to ambient air pollution and incidence of 
brain tumor in total and separately for malignant and non-
malignant tumors.
Materials and Methods
Study Population
We invited 22 cohorts that contributed to earlier analyses 
within the ESCAPE framework on the association of air pol-
lution with lung cancer.26 Of these, we included 12 cohorts 
from 6 European countries (Supplementary Figure S1) 
which had information on brain tumor incidence, at least 
20 cases of brain tumor per cohort, and had the resources 
(statistical analyst available) for participation.
The 12 included cohorts were as follows (Table  1, 
Supplementary Fig. S1):
a. Five Swedish cohorts: European Prospective Investi-
gation into Cancer and Nutrition (EPIC)–Umeå, Swedish 
National Study on Aging and Care in Kungsholmen 
(SNAC-K), Stockholm Screening Across the Lifespan 
Twin study and TwinGene (SALT/Twin gene), Stockholm 
60 years old and IMPROVE study (60 y/IMPROVE), and 
Stockholm Diabetes Prevention Program (SDPP);
b. One Norwegian cohort: Oslo Health Study (HUBRO);
c. One Danish cohort: Diet, Cancer and Health (DCH) study, 
with only Copenhagen included;
d. Two Dutch cohorts: EPIC-Monitoring Project on Risk 
Factors and Chronic Diseases in the Netherlands (EPIC-
MORGEN and EPIC-PROSPECT);
e. One Austrian cohort: Vorarlberg Health Monitoring and 
Prevention Programme (VHM&PP); and
f. Two Italian cohorts: EPIC-Varese and EPIC-Turin.
The majority of cohorts recruited participants from large 
cities and the surrounding suburban or rural communities, 
while few covered large regions of the country, such as 
EPIC-MORGEN in the Netherlands and the VHM&PP cohort 
in Austria. For DCH and VHM&PP, exposure to air pollution 
was assessed for the Copenhagen (DCH) and population 
in the valley (VHM&PP) part of the original cohort. Data 
from the 4 Swedish cohorts from Stockholm (SNAC-K, 
SALT/Twin gene, 60 y/IMPROVE, and SDPP) as well as the 2 
Dutch cohorts (EPIC-MORGEN and EPIC-PROSPECT) were 
pooled by the local analyst, and analyzed as single cohorts, 
named Cardiovascular Effects of Air Pollution and Noise 
in Stockholm (CEANS) and EPIC Netherlands (EPIC-NL), 
respectively. The use of cohort data in ESCAPE was 
approved by the local ethical and data protection authori-
ties. Each cohort study followed the rules for ethics and 
data protection set up in the country in which it was based.
Brain Tumor Definition
Cohort members were followed for brain tumor incidence 
via linkage to national or regional cancer registries among 
cohort members who did not have cancer before cohort 
baseline (excluding nonmelanoma skin cancers). Our main 
outcome was incident primary tumor of the brain, men-
inges, and cranial nerves, defined according to codes of 
the International Classification of Diseases, 10th revision 
(ICD10): C70.0, C71.0–C71.9, C72.2–C72.5, D32.0, D33.0–
D33.2, D33.3, D42.0, D43.0–D43.2, D43.3. We aimed to 
consider the following 5 outcomes: the total of all tumors 
combined; subtypes by malignancy of the tumors: malig-
nant (brain cancer) (C70.0, C71.0–C71.9, C72.2–C72.5) and 
nonmalignant (benign) tumors (D32.0, D33.0–D33.2, D33.3, 
D42.0, D43.0–D43.2, D43.3); and subtypes by the location 
of the tumor: tumors of the brain (ICD10: C71.0–C71.9, 
D33.0–D332, D43.0–D43.2) or tumors of meninges (C70.0, 
D32.0, and D42.0).
Exposure Assessment
We estimated annual average concentrations of air pol-
lution at baseline residence for each cohort participant 
by standardized area-specific land-use regression (LUR) 
models developed within the ESCAPE study, described in 
detail elsewhere.28,29 In brief, the LUR models are based 
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on measurements of NO2 and NOx in all 12 cohorts, and 
PM2.5, PM10, and PM2.5 absorbance in 10 study areas (due 
to budgetary reasons) during one year between October 
2008 and May 2011.30,31 The concentration of PMcoarse was 
calculated as the difference between PM10 and PM2.5. 
Subsequently LUR models were developed for each pollut-
ant in each study area to predict air pollution concentration 
at the baseline residence of the cohort participants. Data 
from the nearest routine monitoring stations were used to 
back-extrapolate the LUR estimates to the baseline year in 
14 of the 15 study areas using the ratio method. We also 
used traffic intensity (annual average number of motor 
vehicles per day) on the nearest road to the exact residen-
tial address at the cohort baseline for each participant, as 
an indicator of exposure to traffic-related air pollution.
Furthermore, we used estimated annual concentra-
tions of 8 elements in PM2.5 and PM10 (copper [Cu], iron 
[Fe], zinc [Zn], sulfur [S], nickel [Ni], vanadium [V], silicon 
[Si], and potassium [K]) with area-specific LUR models 
developed within the framework of the European study 
of Transport-Related Air Pollution and Health Impacts—
Integrated Methodologies for Assessing Particulate 
Matter (TRANSPHORM; www.transphorm.eu/)32,33 (see 
Supplementary material).
Statistical Analyses
We have used a 2-step approach by first estimating the 
association between different air pollutants and brain 
tumor in each cohort, and then combining the estimates 
from each cohort, for each pollutant and each brain tumor 
subtype, by meta-analyses. Pooling of the cohort data was 
not possible due to data transfer and privacy issues.
Cohort-Specific Statistical Analyses
We used Cox proportional hazards (PH) models for the 
cohort-specific analyses, with age as the underlying 
timescale, and censoring at the time of any other cancer 
diagnosis (except nonmelanoma skin cancer), death, emi-
gration (to another country), or end of follow-up, which-
ever came first. We ran a model for total brain tumors, 
and separate models for tumors by malignancy (malig-
nant and nonmalignant brain tumors) and by location 
(tumors in the brain and meninges). We analyzed all air 
pollutants and traffic intensity as linear variables in a sep-
arate single-pollutant model. The potential confounders 
were available from questionnaires at baseline. We speci-
fied 3 confounder models a priori: Model 1, adjusted for 
age (time axis), sex, and calendar time (years of enroll-
ment); Model 2, additionally adjusted for educational 
level (low, medium, or high) and occupation in the petro-
chemical or chemical industry (yes, no); and Model 3, 
adjusted additionally for area-level socioeconomic status 
variables using random effects of the spatial area units 
in each cohort to check for spatial clustering of residuals 
of the models. Various definitions of area-level socioeco-
nomic status were used, including unemployment rate 
at the municipality (EPIC-Umeå, HUBRO, CEANS, and 
EPIC-Varese), mean income in the municipality (DCH, 
VHM&PP), percentage of people with low income in the 
neighborhood (EPIC-NL), and area deprivation index at 
the census block (EPIC-Turin). We a priori chose Model 
3 as the main confounder model. All cohorts except 
VHM&PP had information on education, and only CEANS, 
DCH, EPIC-Varese, and EPIC-Turin had information on 
occupation in the petrochemical or chemical industry. 
Only participants with no missing information in any of 
the exposures and confounders in Model 3 were included 
in all analyses. Individual cohorts adjusted with the max-
imum possible confounders in Model 3.  We performed 
a number of sensitivity analyses within each cohort: We 
restricted analyses to participants who were long-term 
residents (lived at least 10 years at the baseline address); 
we restricted analyses to long-term residents who did not 
move between the baseline and the end of follow-up; we 
added the indicator of rural areas to adjust for different 
degrees of urbanization within the study area; we used 
diagnostic tools to check the PH assumption for the cat-
egorical predictors in Model 3, and stratified the Cox 
model for the predictors that did not meet the PH assump-
tion. We examined the shape of the association between 
each pollutant and brain tumor by inputting the expos-
ure term as a natural cubic spline with 2 inner knots (ie, 
3 degrees of freedom) and by comparing the model fit of 
the linear and spline models by a likelihood ratio test. All 
cohort-specific analyses were performed in Stata v10–12 
using a common script, except for models with random 
effects, for which we used R software v2.11–2.15.
Meta-Analyses
We performed meta-analyses of cohort-specific effect 
estimates with the DerSimonian-Laird method with ran-
dom effects.34 As main analyses, we performed separate 
meta-analyses for each of 7 pollutants for malignant brain 
tumors in 12 cohorts, and for nonmalignant and total 
brain tumors in 6 cohorts. Additionally, as presented in the 
Supplementary material, we performed meta-analyses for 
elemental components of PM2.5 and PM10 and malignant 
brain tumors, and a number of sensitivity analyses. We 
calculated hazard ratios (HRs) and 95% CIs for fixed incre-
ments that were chosen to cover the range in concentra-
tions within the different cohorts and to keep increments 
broadly comparable between pollutants. We evaluated the 
heterogeneity between cohort-specific results by applying 
the chi-square test from Cochran’s Q statistic, which was 
quantified by the I2 statistic.35 We tested effect modification 
with a meta-analysis of the pooled estimates from the dif-
ferent strata and by computing the χ2 test of heterogeneity. 
We considered cohort-specific estimates to be significantly 
heterogeneous when I2 was >50% or the P-value of the chi-
square test was <0.05. We investigated the robustness of 
the results for malignant brain tumors by examining the 
effect of all pollutants after excluding the VHM&PP from the 
meta-analyses, since this was the largest and most influen-
tial cohort which lacked the data on tumor in the meninges, 
and had the smallest number of confounders available in 
Model 3. We used Stata v12.1 for all meta-analyses.
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Results
Study Population
All 12 cohorts had data on malignant brain tumors 
(Table  1), where 466 primary malignant brain tumors 
were diagnosed in a total of 282 194 men and women dur-
ing a mean follow-up of 13.3 years or 4 186 476 person-
years. Six of these cohorts (5 from Sweden: EPIC-Umeå 
and CEANS [consisting of 4 cohorts] and the Austrian 
VHM&PP) did not have information on nonmalignant 
tumors. Of 106 786 men and women from 6 cohorts 
with data on both nonmalignant and malignant tumors 
(HUBRO, DCH, EPIC-NL [consisting of 2 cohorts], EPIC-
Varese, and EPIC-Turin), 366 in total developed primary 
brain tumors during a mean follow-up of 12.6  years 
(1 319 523 person-years), of which 176 (48%) were non-
malignant and 190 (52%) malignant. Of these 6 cohorts, 
EPIC-Varese did not have information on tumor subtype 
by location (meninges or brain). Thus, analyses of the 
subtypes of brain tumors by location were based on 5 
cohorts with complete data on total brain tumors (malig-
nant and nonmalignant) and on brain tumor location 
(meninges or brain): HUBRO, DCH, EPIC-NL (consisting 
of 2 cohorts), and EPIC-Turin. Among the 96 215 subjects 
from these 5 cohorts, 303 developed brain tumor in total 
during a mean follow-up of 12.7  years or 1 205 547 per-
son-years. Of these 303 brain tumors, 115 (38%) were in 
the meninges and 188 (62%) in the brain.
Mean age at the time of enrollment ranged from 
41.3 years in VHM&PP to 56.8 years in DCH (Table 1). The 
proportion of women ranged from 43.9% in EPIC-Turin 
to 78.9% in EPIC-Varese, while the proportion of highly 
educated ranged from 7.1% in EPIC-Varese to 45.2% in 
HUBRO. VHM&PP did not have data on education (see 
Supplementary Table S1).
Air Pollution Exposure
The air pollution levels at residence varied substantially 
within and between study areas, with increasing levels from 
Northern to Southern study areas (Table  2). EPIC-Umeå 
and EPIC-Varese did not have data on PM, and EPIC-Varese 
had none on traffic intensity. The mean concentration of 
PM2.5 ranged from 7.1 µg/m
3 in CEANS (Sweden) to 30.2 µg/
m3 in EPIC-Turin (Italy). NO2 ranged from 5.3 µg/m
3 in EPIC-
Umeå (Sweden) to 53.0 µg/m3 in EPIC-Turin. Average traf-
fic intensity on the nearest road was lowest in EPIC-Umeå 
(849 vehicles/day) and highest in EPIC-Turin (4044 vehicles/
day). Mean levels of PM2.5 and PM10 elements also varied 
substantially between study areas (Supplementary Table 
S2). The estimates in this study were given per fixed incre-
ments (10 µg/m3 for PM10 and NO2, 5 µg/m
3 for PM2.5, etc), 
which were selected a priori by a protocol for the entire 
ESCAPE project, as they reflect broadly comparable con-
trasts in exposure for the different pollutants and are most 
commonly used in literature and in meta-analyses. These 
contrasts/increments should be considered in the context 
of the mean air pollution concentrations in different areas. 
For example, 10 µg/m3 represents 58% of the average PM10 
concentration in Copenhagen, Denmark and only 21% of 
average PM10 concentration in Turin, Italy.
Associations Between Air Pollutants and 
Malignant Brain Tumor in 12 Cohorts
We found positive, statistically nonsignificant association 
between malignant brain tumor and PM2.5 absorbance 
(HR = 1.67; 95% CI: 0.89–3.14 per 10–5/m; P = 0.11) in the fully 
adjusted model (Model 3), with moderate heterogeneity in 
the individual cohort estimates (I2 = 39.9%) (Table 3, Fig. 1). 
Summary estimates for PM2.5 absorbance were enhanced 
or remained unchanged in the sensitivity analyses (see 
Table 2 Mean (standard deviation) of the air pollution and traffic intensity levels at the 282 194 participants’ addresses in 12 European cohorts
Cohort PM2.5,
µg/m3
PM2.5 
absorbance,
10–5/m
PM10,  
µg/m3
PMcoarse,  
µg/m3
NO2,
µg/m3
NOx,
µg/m3
Traffic Intensity on  
the Nearest Road  
(vehicles/day)
EPIC-Umeå, Sweden – – – – 5.3 (2.5) 8.8 (5.8) 849 (1521)
HUBRO, Norway 8.9 (1.3) 1.2 (0.3) 13.5 (3.1) 4.0 (2.0) 20.9 (8.0) 38.2 (15.5) 2509 (5098)
CEANS, Swedena 7.1 (1.3) 0.6 (0.2) 14.7 (4.1) 7.1 (3.1) 10.8 (4.6) 19.1 (10.2) 1557 (4494)
DCH, Denmark 11.3 (0.8) 1.2 (0.2) 17.2 (1.9) 5.7 (1.0) 16.5 (7.0) 27.2 (18.5) 3109 (7412)
EPIC-NL, Netherlandsb 16.9 (0.6) 1.4 (0.2) 25.4 (1.5) 8.5 (0.9) 25.2 (6.2) 37.9 (12.3) 1290 (3797)
VHM&PP, Austria 13.6 (1.2) 1.7 (0.2) 20.7 (2.4) 6.7 (0.9) 20.0 (5.5) 40.1 (9.6) 1718 (3647)
EPIC-Varese, Italy – – – – 43.4 (17.3) 85.9 (41.9) –
EPIC-Turin, Italy 30.2 (1.6) 3.1 (0.4) 46.6 (4.1) 16.6 (2.7) 53.0 (10.3) 96.1 (20.3) 4044 (9596)
EPIC, European Prospective Investigation into Cancer and Nutrition; HUBRO, Oslo Health Study; CEANS, Cardiovascular Effects of Air Pollution  
and Noise in Stockholm; DCH, Danish Diet, Health and Cancer cohort; VHM&PP, Vorarlberg Health Monitoring and Prevention Programme.  
aPooled data from the 4 cohorts from Stockholm, Sweden: SNAC-K, SALT/Twin gene, 60 y/IMPROVE, and SDPP. bPooled data from 2 Dutch  
cohorts: EPIC-MORGEN and EPIC-PROSPECT.
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Table 3 Association between exposure to air pollution and malignant brain tumor incidence in 12a European cohorts
Fixed Increase N Cohorts N Model 1c
HR (95% CI)
Model 2d
HR (95% CI)
Model 3e
HR (95% CI)
P-value  
Model 3
I2 (%)
(P-value)
PM2.5 5 µg/m
3 10b 246 626 1.04 (0.66–1.63) 1.01 (0.64–1.60) 0.98 (0.62–1.56) 0.94 0.0 (0.44)
PM2.5  
absorbance
10−5/m 10b 246 626 1.76 (0.90–3.43) 1.72 (0.91–3.25) 1.67 (0.89–3.14) 0.11 39.9 (0.14)
PM10 10 µg/m
3 10b 246 626 1.17 (0.73–1.87) 1.15 (0.74–1.78) 1.15 (0.72–1.83) 0.55 13.8 (0.33)
PMcoarse 5 µg/m
3 10b 246 626 1.03 (0.72–1.47) 1.02 (0.71–1.46) 1.00 (0.69–1.45) 0.99 0.0 (0.82)
NO2 10 µg/m
3 12a 282 194 1.04 (0.82–1.33) 1.05 (0.83–1.32) 1.04 (0.82–1.31) 0.75 55.2 (0.03)
NOx 20 µg/m
3 12a 282 194 1.06 (0.85–1.31) 1.06 (0.86–1.30) 1.05 (0.86–1.28) 0.63 47.8 (0.06)
Traffic intensity 5000 vehicles/
day
10b 282 194 1.08 (1.00–1.16) 1.07 (0.99–1.16) 1.08 (0.99–1.16) 0.07 0.0 (0.75)
aEPIC-Umeå, CEANS (pooled data from the 4 cohorts from Stockholm, Sweden: SNAC-K, SALT/Twin gene, 60 y/IMPROVE, and SDPP), HUBRO, DCH, 
EPIC-NL (pooled data from 2 cohorts: EPIC-MORGEN and EPIC-PROSPECT), VHM&PP, EPIC-Varese, and EPIC-Turin; bCEANS (pooled data from the  
4 cohorts from Stockholm, Sweden: SNAC-K, SALT/Twin gene, 60 y/IMPROVE, and SDPP), HUBRO, DCH, EPIC-NL (pooled data from 2 cohorts:  
EPIC-MORGEN and EPIC-PROSPECT), VHM&PP, and EPIC-Turin.
cAdjusted for age, sex, and year of enrollment. dModel 1 plus educational, and occupation in petrochemical industry; eModel 2 plus area-level  
socioeconomic status.
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.438)
ID
VHM&PP
CEANS
EPIC-NL
EPIC-Turin
Study
HUBRO
DCH
0.98 (0.62, 1.56)
HR (95% CI)
1.17 (0.64, 2.17)
0.30 (0.08, 1.12)
2.98 (0.28, 31.69)
1.01 (0.24, 4.32)
0.61 (0.12, 3.20)
1.41 (0.32, 6.17)
100.00
Weight
56.47
12.28
3.79
10.06
%
7.68
9.72
1.0316 31.7
PM2.5
NOTE: Weights are from random effects analysis
Overall  (I-squared = 39.9%, p = 0.139)
Study
ID
EPIC-Turin
DCH
HUBRO
CEANS
EPIC-NL
VHM&PP
1.67 (0.89, 3.14)
HR (95% CI)
0.88 (0.29, 2.63)
3.59 (1.19, 10.87)
3.62 (0.83, 15.70)
0.10 (0.01, 1.73)
2.20 (0.60, 8.06)
1.45 (0.73, 2.85)
100.00
%
Weight
18.99
18.75
13.05
4.45
15.46
29.30
1.00585 171
PM2.5absorbance
NOTE: Weights are from random effects analysis
Overall  (I-squared = 13.8%, p = 0.326)
ID
Study
VHM&PP
DCH
HUBRO
EPIC-NL
EPIC-Turin
CEANS
1.15 (0.72, 1.83)
HR (95% CI)
1.24 (0.66, 2.33)
3.20 (0.92, 11.16)
0.58 (0.12, 2.70)
3.18 (0.42, 24.04)
0.92 (0.30, 2.80)
0.69 (0.29, 1.67)
100.00
Weight
%
36.86
12.29
8.39
5.01
15.11
22.34
1.0416 24
PM10
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.818)
EPIC-NL
VHM&PP
DCH
CEANS
ID
EPIC-Turin
HUBRO
Study
1.00 (0.69, 1.45)
1.47 (0.26, 8.39)
1.06 (0.46, 2.43)
2.38 (0.47, 11.97)
0.77 (0.43, 1.39)
HR (95% CI)
1.03 (0.43, 2.47)
1.21 (0.45, 3.25)
100.00
4.45
19.81
5.18
39.15
Weight
17.55
13.86
%
1.0835 12
PMcoarse
Fig. 1 Adjusted associations between malignant brain tumor and PM2.5, PM2.5 absorbance, PM10, and PMcoarse (main Model 3) in 10 European 
cohorts (CEANS [pooled data from the 4 cohorts from Stockholm, Sweden: SNAC-K, SALT/Twin gene, 60 y/IMPROVE, and SDPP], HUBRO, DCH, 
EPIC-NL [pooled data from 2 cohorts: EPIC-MORGEN and EPIC-PROSPECT], VHM&PP, and EPIC-Turin) result from cohort-specific analyses and 
random-effects analyses.
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Supplementary Table S3). We found borderline significantly 
positive associations with traffic intensity on the nearest 
road (HR = 1.08; 95% CI: 0.99–1.16 per 5000 vehicles/day, P 
value = 0.07), but it is notable that 3 cohorts had HR above 
1, and 4 cohorts had HR below 1 (Table 3, Fig. 2). We found 
weak positive associations with PM10, NO2, and NOx, and 
none with PM2.5 or PMcoarse. There was moderate or no het-
erogeneity in the summary estimates, except for NO2 and 
NOx, which showed substantial, statistically significant het-
erogeneity between individual cohort estimates.
HRs for all pollutants were slightly attenuated after 
adjustment for individual-level confounders (Table  3). 
There was no evidence of deviation from linearity in 
associations between air pollutants and total brain tumor 
(results not shown).
Associations Between Elemental Components of 
PM and Malignant Brain Tumor
In the secondary analyses of the elemental components 
of PM2.5 and PM10, no statistically significant associations 
were detected for any component and malignant brain 
tumor. We detected the strongest association with the V 
component of PM2.5 (HR = 1.40; 95% CI: 0.75–2.60 per 2 ng/
m3) and PM10 (HR = 1.31; 95% CI: 0.69–2.49 per 3 ng/m
3) 
and the Ni component of PM2.5 (HR = 1.27; 95% CI: 0.44–
3.64 per 1 ng/m3) and PM10 (HR = 1.28; 95% CI: 0.98–1.66 
per 2 ng/m3), though with statistically significant hetero-
geneity between individual cohort estimates for the Ni 
component of PM2.5 (I
2  = 76.3) (Supplementary Table S4 
and Supplementary Figure S2). We also found a posi-
tive association with the copper component of PM2.5 and 
PM10, and the iron and sulfur components of PM2.5 (but 
not PM10).
Associations Between Air Pollutants and Total 
and Nonmalignant Brain Tumor in Six Cohorts
We found no association between any pollutant and non-
malignant brain tumor (Table 4), and even strong inverse 
association with PMcoarse and PM10 (Table 4, Supplementary 
Figures S3 and S4). We found positive but statistically 
NOTE: Weights are from random effects analysis
Overall  (I-squared = 55.2%, p = 0.029)
VHM&PP
DCH
EPIC-Umeå
HUBRO
ID
CEANS
EPIC-Turin
EPIC-NL
EPIC-Varese
Study
1.04 (0.82, 1.31)
0.96 (0.73, 1.26)
1.43 (1.06, 1.93)
0.72 (0.23, 2.22)
1.62 (0.98, 2.70)
HR (95% CI)
0.37 (0.10, 1.31)
0.87 (0.57, 1.32)
1.30 (0.77, 2.17)
0.79 (0.59, 1.05)
100.00
19.25
18.25
3.68
11.62
Weight
3.00
14.23
11.43
18.54
%
1.105 9.56
NO2
NOTE: Weights are from random effects analysis
Overall  (I-squared = 47.8%, p = 0.063)
CEANS
DCH
EPIC-Turin
EPIC-Varese
EPIC-NL
HUBRO
VHM&PP
ID
EPIC-Umeå
Study
1.05 (0.86, 1.28)
0.32 (0.08, 1.26)
1.26 (1.02, 1.57)
0.87 (0.56, 1.37)
0.82 (0.64, 1.04)
1.11 (0.64, 1.92)
1.48 (0.90, 2.44)
1.21 (0.90, 1.63)
HR (95% CI)
0.82 (0.32, 2.11)
100.00
2.03
22.64
12.14
21.04
9.31
10.68
18.23
Weight
3.94
%
1.082 12.2
NOx
NOTE: Weights are from random effects analysis
Overall  (I-squared = 0.0%, p = 0.746)
EPIC-Umeå
DCH
VHM&PP
HUBRO
EPIC-NL
CEANS
ID
EPIC-Turin
Study
1.08 (0.99, 1.16)
1.10 (0.52, 2.30)
1.10 (1.00, 1.21)
1.09 (0.91, 1.31)
0.93 (0.56, 1.57)
0.96 (0.61, 1.50)
0.48 (0.12, 1.90)
HR (95% CI)
0.87 (0.61, 1.24)
100.00
1.11
69.33
19.07
2.24
3.01
0.33
Weight
4.90
%
1.124 8.07
Trafnear and Brain cancer
Fig. 2 Adjusted associations between malignant brain tumor and NO2, NOx, and traffic intensity on the nearest road (main Model 3)  in 12 
European cohorts (aEPIC-Umeå, CEANS [pooled data from the 4 cohorts from Stockholm, Sweden: SNAC-K, SALT/Twin gene, 60 y/IMPROVE, and 
SDPP], HUBRO, DCH, EPIC-NL [pooled data from 2 cohorts: EPIC-MORGEN and EPIC-PROSPECT], VHM&PP, EPIC-Varese, and EPIC-Turin) result 
from cohort-specific analyses and random-effects analyses.
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nonsignificant associations between total brain tumor and 
PM2.5 absorbance (HR = 1.58; 95% CI: 0.73–3.40 per 10
–5/m) 
and statistically significant association with traffic intensity 
on the nearest road (HR = 1.07; 95% CI: 1.00–1.14 per 5000 
vehicles/day) (Table 4, Supplementary Figures S5 and S6). 
It is notable that for traffic intensity, only a single cohort 
had HR above 1, and the rest below 1.
Associations Between Air Pollutants and Brain 
Tumor by Malignancy in Six Cohorts
In the analyses based on 6 cohorts with data on both 
malignant and nonmalignant brain tumors, HRs for all 
pollutants, except for traffic intensity on the nearest road, 
were higher for malignant brain tumors (Supplementary 
Table S5 and Supplementary Figures S7 and S8) than for 
nonmalignant brain tumors (Supplementary Figures S5 
and S6), reaching statistical significance for malignant 
tumors and PM2.5 absorbance (HR = 2.03; 95% CI: 1.05–3.91 
per 10–5/m).
Associations Between Air Pollutants and Brain 
Tumor by Location
In the analyses in 5 cohorts with data on all brain tumors 
and subtypes by location (brain or meninges), there was 
no clear pattern (Supplementary Table S6). HRs for the 
most pollutants were generally higher for tumors in the 
brain (Supplementary Figures S9 and S10) than in the 
meninges (Supplementary Figures S11 and S12), except 
for PM2.5, for which a very strong positive association was 
detected (HR = 2.53; 95% CI: 0.87–7.41; I2 = 0.0, per 5 µg/m3), 
and traffic intensity on the nearest road.
A schematic presentation of a number of analyses pre-
sented in the paper is given in Supplementary Figure S13.
Discussion
In this large, multicenter European study, we found sug-
gestive evidence of an association between long-term 
exposure to the traffic-related marker PM2.5 absorbance 
and risk of malignant brain tumors, and no association 
with nonmalignant brain tumors.
Comparison with Previous Studies
Our results suggesting relevance of traffic-related PM air 
pollution, in terms of PM2.5 absorbance, for malignant 
brain tumor are novel. Lack of statistically significant asso-
ciations between malignant brain tumor incidence and 
PM2.5, PM10, and NO2 in our study agrees with the findings 
by McKean-Cowdin et al from 2009, based on a US Cancer 
Prevention Study, of no association between brain cancer 
mortality (1284 cases) and residential exposure to PM2.5, 
PM10, or NO2 (all HRs below 1).
22 McKean-Cowdin et al had 
data on only brain cancer mortality, which, in contrast to 
incidence, captures more aggressive types of malignant 
brain cancers. Our results agree with a study by Jørgensen 
et al24 of 28 731 female nurses from a Danish Nurse Cohort 
(121 cases of total brain tumor) that found no association 
of PM2.5 or PM10 with malignant brain tumor incidence 
(HRs for all pollutants below 1), consistent with McKean-
Cowdin et  al.22 We found the strongest effects for PM2.5 
absorbance, which captures a fraction of PM2.5 originating 
from incomplete combustion from motorized traffic, highly 
correlated to elemental carbon.36 PM2.5 absorbance may be 
a better proxy for traffic-related particles in the ultrafine-
particle (UFP) size range (diameter  <100  nm) than PM2.5. 
In Augsburg, Germany, average UFP level was highly 
correlated with PM2.5 absorbance (correlation coefficient 
Table 4 Associationa between long-term exposure to air pollution and benign and total brain tumor incidence in 6a European cohorts
Benign Brain Tumor Total Brain Tumor
Fixed Increase N Cohorts N HR (95% CI) P-value I 2 (%)
(P-value)
HR (95% CI) P-value I 2 (%)
(P-value)
PM2.5 5 µg/m
3 5b 96 215 1.12 (0.46–2.73) 0.81 0.0 (0.39) 1.13 (0.61–2.09) 0.69 0.0 (0.51)
PM2.5 
absorbance
10−5/m 5b 96 215 1.01 (0.38–2.71) 0.98 49.8 (0.11) 1.58 (0.73–3.40) 0.25 63.6 (0.04)
PM10 10 µg/m
3 5b 96 215 0.54 (0.14–2.13) 0.38 60.3 (0.05) 0.97 (0.36–2.57) 0.95 68.3 (0.02)
PMcoarse 5 µg/m
3 5b 96 215 0.51 (0.24–1.10) 0.08 0.0 (0.68) 0.87 (0.55–1.38) 0.56 0.0 (0.68)
NO2 10 µg/m
3 6c 106 786 0.95 (0.72–1.267 0.73 50.9 (0.09) 1.04 (0.83–1.31) 0.74 67.0 (0.02)
NOx 20 µg/m
3 6c 106 786 0.97 (0.75–1.25) 0.80 49.3 (0.10) 1.01 (0.84–1.22) 0.91 59.6 (0.04)
Traffic 
intensity
5000 vehicles/ 
day
5b 96 215 1.07 (0.97–1.18) 0.17 0.0 (0.82) 1.07 (1.00–1.14) 0.04 0.0 (0.46)
P-value: for Model 3; aModel 3, adjusted for age, sex, year of enrollment, education, occupation in petrochemical industry, and area-level  
socioeconomic status; bHUBRO, DCH, EPIC-NL (which includes 2 cohorts: EPIC-MORGEN and EPIC-PROSPECT), and EPIC-Turin; cHUBRO, DCH,  
EPIC-NL (pooled data from 2 Dutch cohorts: EPIC-MORGEN and EPIC-PROSPECT), EPIC-Varese, and EPIC-Turin.
429Andersen et al. Air pollution and brain tumor
N
eu
ro-
O
n
colog
y
[R]  =  0.81), but the correlations with NO2 and NOx were 
even higher.37 In Amsterdam, average UFP was highly cor-
related with PM absorbance (R = 0.85) at 46 sites, and cor-
relations with PM2.5 and PMcoarse were lower.
38 UFPs are of 
particular concern with respect to brain, because experi-
mental studies in animals indicate that inhaled UFPs can 
reach the brain by crossing the blood–brain barrier or dir-
ectly via nasal passage and olfactory neurons, and accu-
mulate in the brain,16,39,40 causing inflammation, oxidative 
stress, and DNA damage.13,41,42
Our results of weakly positive, statistically nonsignifi-
cant associations with NO2 and NOx disagree with a study 
from 2011 by Raaschou-Nielsen et  al on malignant brain 
tumor incidence (95 cases) in 54 304 participants from the 
DCH cohort which detected strong association with NOx 
(HR = 2.28; 95% CI: 1.25–4.19 per 100 µg/m3) and proximity 
to major street (<50 m) (HR = 1.89; 95% CI: 1.07–3.36).23 In 
the current analysis including half of the DCH cohort par-
ticipants living in Copenhagen, association for NOx in the 
DCH cohort was also strongly positive and statistically sig-
nificant (HR = 1.22; 95% CI: 1.05–1.42 per 20 µg/m3), as it 
was with traffic intensity (HR = 1.09; 95% CI: 1.02–1.17 per 
5000 motor vehicles/day) (Fig. 2), showing consistency in 
the DCH cohort with 2 different estimation methods for 
NOx and 2 different proxies for traffic intensity. However, 
2 recent Danish studies24,25 did not reproduce this strong 
association between NOx and brain tumor detected in DCH, 
in agreement with our findings. Poulsen et al in a Danish 
nationwide case-control study (2000–2009) with 4183 brain 
tumor cases in total, found only a weakly positive asso-
ciation with NOx (HR = 1.11; 95% CI: 0.84–1.46 per 100 µg/
m3),25 in line with our findings, but detected a statistically 
significant positive association with non-glioma tumors 
(HR  =  1.53; 95% CI: 1.02–2.29 per 100  µg/m3). Similarly, 
Jørgensen et  al24 in 28 731 female nurses from a Danish 
Nurse Cohort (121 brain tumor cases) found no association 
with NOx (HR  =  1.02; 95% CI: 0.93–1.12 per 10.2  µg/m
3), 
agreeing with the current study. However, neither Poulsen 
et al nor Jørgensen et al had data on the traffic intensity 
on the nearest road. While we detected the strongest asso-
ciations with malignant tumors, both Poulsen et al25 and 
Jørgensen et al24 found slightly stronger effects for non-
malignant brain tumors. Overall, evidence from this study 
does not support association between PM2.5, PM10, NO2, 
and NOx with brain tumor development but suggests that 
PM originating from traffic, in terms of PM2.5 absorbance, 
may play a role in the development of malignant brain 
tumors. However, due to high heterogeneity in findings in 
the existing literature, it is premature to draw a conclusion 
on the causal relationship between air pollution and brain 
tumor. More studies with data from long-term exposure to 
PM2.5 absorbance, and preferably UFPs, are needed to con-
firm our novel findings.
Particle Composition Findings
We present a novel suggestive finding of the relevance 
of V and Ni components of PM2.5 and PM10 for malignant 
brain tumor development (Supplementary Table S5 and 
Supplementary Figure S2). Environmental exposure to 
V occurs in areas of persistent burning of fossil fuel. This 
metal is known to induce oxidative stress and oligodendro-
cyte damage and has been linked with carcinogenic, 
immunotoxic, and neurotoxic insults.43 Ni is a transitional 
heavy metal originating primarily from the combustion of 
fossil fuels,44 found to be carcinogenic to humans, causing 
cancers of the lung and of the nasal cavity.45 The Ni compo-
nent of PM10 was the PM element that showed the strong-
est association with lung cancer incidence (HR = 1.59; 95% 
CI: 1.12–2.26 per 2 ng/m3) in a related study in 14 European 
cohorts.46 These novel results call for replication in other 
studies and should be taken with caution, especially for Ni 
component PM2.5, where a large heterogeneity between 
individual cohorts is observed.
Strengths and Limitations
Our study benefited from a multicenter design and a large 
number of subjects recruited from general populations 
from around Europe, with large variation in air pollution 
levels, well-defined information on the brain tumor risk 
factors, and standardized definition of brain tumor from 
national and regional cancer registers. The major strength 
of our study is the standardized exposure assessment for 
a number of different air pollutants and PM elements, and 
standardized statistical analyses across all cohorts. The air 
pollution LUR models have been validated and were ear-
lier linked to lung cancer.26 We adjusted the analyses for 
the most important risk factors but found little evidence of 
confounding in air pollution estimates. Finally, the strength 
of the study is that we had data on nonmalignant brain 
tumors.
Of 22 original ESCAPE cohorts, we included only the 12 
cohorts which had data on brain tumor, at least 20 cases of 
brain tumor in total, and resources in terms of a statistical 
analyst to perform analyses. Of the cohorts not included 
in current analyses are the cohorts from Southern Europe, 
including those from Greece (EPIC-Athens), Italy (SIDRIA-
Rome), and Spain (San Sebastian and Basque country), as 
well as those from the United Kingdom (UK) (EPIC-Oxford), 
Switzerland (SAPALDIA), France (E3N), and Germany 
(SALIA and KORA), while all the Nordic and Dutch cohorts 
(except Finish FINRISK) are included. Thus, some of the 
original 22 ESCAPE cohorts with highest levels of air pol-
lution from Southern Europe are missing from current 
analyses, while there is an overrepresentation of cohorts 
from Northern countries, with lower air pollution levels.
Weakness of our study is lack of data on brain tumor 
subtypes in all 12 cohorts. We have detected significant 
positive association between PM2.5 absorbance and 
malignant brain tumor only in 6 cohorts which had infor-
mation on all brain tumors (HR = 2.12; 95% CI: 1.06–4.25 
per 10−5/m; see Supplementary Table S5), but not in a 
larger sample of a total of 12 cohorts with information 
on malignant tumors (HR  =  1.67; 95% CI: 0.89–3.14 per 
10−5/m). However, all sensitivity analyses of associations 
between PM2.5 absorbance and malignant brain tumor 
based on 6 cohorts showed enhanced HRs, ranging 
from 1.67 to 2.37 (see Supplementary Table S3), suggest-
ing that the associations may be real and rather robust. 
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Furthermore, we lacked information on brain tumor hist-
ology and morphology and could not study whether air 
pollution differentially affects more aggressive types of 
brain tumors, such as glioblastomas or anaplastic astro-
cytomas, opposed to more nonmalignant tumors such 
as meningiomas or low-grade gliomas. We lacked infor-
mation on detailed occupational exposures to chemi-
cals that may be related to brain tumor risk, apart from 
a crude definition of occupation in the petrochemical 
industry available in 8 out of 12 cohorts. We also lacked 
data on other potential risk factors, such as genetic pre-
disposition, residential radon exposure, occupation in 
agriculture, and exposure to radiation to head and neck, 
but all of these are most likely not related to air pollu-
tion levels at residence. We used air pollution exposure 
estimated close to the time of the brain tumor diagnosis, 
and lack data on distant exposures during adulthood and 
early life, which may be more relevant for the develop-
ment of brain tumor. We used an LUR model in this study 
developed on air pollution measurements between 2008 
and 2011 but applied them to baseline addresses typic-
ally 10 to 15 years earlier, which likely resulted in some 
exposure misclassification. Several studies have docu-
mented stable spatial contrast of NO2 over study periods 
of 10–15 years.47–49 As motorized traffic is a major source 
of NO2, spatial contrasts likely have been stable for other 
traffic-related pollutants including PM2.5 absorbance. 
Another weakness of the study is that we used infor-
mation on air pollution and confounders at the cohort 
baseline and did not have information on changes over 
time. Furthermore, we lacked information on partici-
pants’ activity patterns, time spent outdoors and away 
from home, commuting to work, etc. Exposure misclassi-
fication and lack of early-life exposures to air pollution 
may have biased our estimates toward zero, meaning 
that real associations would be even stronger than those 
observed here. Majority of the cohorts included in cur-
rent analyses were recruited from urban areas, typic-
ally large cities and surrounding areas, except VHM&PP, 
which included primarily rural communities and several 
towns. However, there is still large variation in air pol-
lution levels within the cohorts (Table 2), and especially 
between the cohorts with example of NO2 levels ranging 
from 8.8 µg/m3 in Umeå, Sweden to 96.1 in Turin, Italy.
Conclusion
In a large meta-analysis based on 12 European cohorts, 
on long-term exposure to ambient air pollution and brain 
tumor incidence, we found a suggestive evidence of an 
association between traffic-related PM2.5 absorbance and 
malignant brain tumors, and no association with overall or 
nonmalignant brain tumors.
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Supplementary material is available at Neuro-Oncology 
online.
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